Structures published

Total: 32

C₆₀H₅₀In₂N₂O₁₇

Gu, Ja-Min Kim, Sung-Jin Kim, Youngmee Huh, Seong

CrystEngComm (2012) 14, 5 1819

a=23.760(5)Å b=39.331(8)Å c=40.610(9)Å

α=90.00° β=90.00° γ=90.00°

C₅₆H₃₂In₂O₁₆

Gu, Ja-Min Kim, Sung-Jin Kim, Youngmee Huh, Seong

CrystEngComm (2012) 14, 5 1819

a=23.088(3)Å b=39.262(5)Å c=41.133(5)Å

α=90.00° β=90.00° γ=90.00°

C₃₂H₁₆InNO₈

Gu, Ja-Min Kim, Sung-Jin Kim, Youngmee Huh, Seong

CrystEngComm (2012) 14, 5 1819

a=12.251(3)Å b=18.631(4)Å c=20.976(4)Å

α=90.00(3)° β=90.00(3)° γ=90.00(3)°

C₂₆H₂₄N₂O₄Zn

Gu, Ja-Min Kwon, Tae-Hwan Park, Ji-Hyun Huh, Seong

Dalton transactions (Cambridge, England : 2003) (2010) 39, 24 5608-5610

a=9.8933(12)Å b=18.1647(15)Å c=13.4537(16)Å

α=90.00° β=94.792(4)° γ=90.00°

C₂₃H₂₉ClFN₃O_4,H₂O

Zhou, Xin-Bo Zhu, Jian-Rong Gu, Jian-Ming Hu, Xiu-Rong

Acta Crystallographica Section C (2018) 74, 6

a=12.3225(9)Å b=14.5183(8)Å c=13.8141(8)Å

α=90° β=98.361(2)° γ=90°

Regorafenib crystalline form I

C₂₁H₁₅ClF₄N₄O₃

Sun, Meng-Ying Wu, Su-Xiang Zhou, Xin-Bo Gu, Jian-Ming Hu, Xiu-Rong

Acta Crystallographica Section C (2016) 72, 4 291-296

a=7.6972(4)Å b=24.3703(12)Å c=11.3580(7)Å

α=90.00° β=93.545(2)° γ=90.00°

Regorafenib monohydrate

C₂₁H₁₅ClF₄N₄O_3,H₂O

Sun, Meng-Ying Wu, Su-Xiang Zhou, Xin-Bo Gu, Jian-Ming Hu, Xiu-Rong

Acta Crystallographica Section C (2016) 72, 4 291-296

a=4.7783(2)Å b=21.9538(9)Å c=20.5581(8)Å

α=90.00° β=92.3410(10)° γ=90.00°

Febuxostat

C₁₆H₁₆N₂O₃S_,C₂H₄O₂

Wu, Min Hu, Xiu-Rong Gu, Jian-Ming Tang, Gu-Ping

Acta Crystallographica Section E (2015) 71, 5 o295-o296

a=7.684(2)Å b=10.580(3)Å c=12.059(3)Å

α=84.897(5)° β=84.674(4)° γ=71.081(5)°

4-(2-Carbamoyl-1-benzofuran-5-yl)-1-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-ium chloride methanol monosolvate

C₂₆H₂₈N₅O_2,Cl_,CH₄O

Hu, Xiu-Rong Ye, Jia-Li Gu, Jian-Ming

Acta Crystallographica Section E (2016) 72, 12 1783-1785

a=10.5572(5)Å b=11.0764(4)Å c=11.4408(5)Å

α=104.6220(10)° β=97.327(2)° γ=90.6950(10)°

Canagliflozin

2(C₂₄H₂₅FO₅S)_,H₂O

Liu, Kai-Hang Gu, Jian-Ming Hu, Xiu-Rong Tang, Gu-Ping

Acta Crystallographica Section E (2016) 72, 5 734-736

a=8.4259(4)Å b=11.4264(7)Å c=45.706(2)Å

α=90.00° β=90.00° γ=90.00°

Vortioxetine

C₁₈H₂₂N₂S

Zhou, Xin-Bo Gu, Jian-Ming Sun, Meng-Ying Hu, Xiu-Rong Wu, Su-Xiang

Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 8 883-885

a=7.6160(4)Å b=8.3267(5)Å c=13.9011(7)Å

α=84.999(2)° β=77.6310(10)° γ=74.347(2)°

1-{2-[(2,4-Dimethylphenyl)sulfanyl]phenyl}piperazine methanol monosolvate

C₁₈H₂₂N₂S_,CH₄O

Zhou, Xin-Bo Gu, Jian-Ming Sun, Meng-Ying Hu, Xiu-Rong Wu, Su-Xiang

Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 8 883-885

a=13.2100(7)Å b=18.1500(9)Å c=8.1746(4)Å

α=90.00° β=104.378(2)° γ=90.00°

N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfanyl)-2-hydroxy- 2-methylpropionamide chloroform solvate

C₁₈H₁₄F₄N₂O₂S_,CHCl₃

Tang, Gu-Ping Gu, Jian-Ming

Acta Crystallographica Section E (2005) 61, 10 o3184-o3186

a=8.8442(9)Å b=10.4591(9)Å c=13.3190(10)Å

α=110.718(4)° β=90.895(2)° γ=105.595(2)°

1-Phenyl-2-(toluene-4-sulfonyl)ethanone

C₁₅H₁₄O₃S

Gu, Jian-Ming Zhang, You-Chu Hu, Xiu-Rong

Acta Crystallographica Section E (2004) 60, 6 o1115-o1116

a=15.8077(7)Å b=5.4113(2)Å c=15.8940(9)Å

α=90° β=95.343(2)° γ=90°

C₁₉H₁₈BrN₃O₃

Wu, Jun Zhang, Pei-Zhi Yu, Qing-Sen Hu, Xiu-Rong Gu, Jian-Min

Acta Crystallographica, Section E: Structure Reports Online (2003) 59, 9 o1393-o1394

a=8.7821(5)Å b=10.3347(6)Å c=10.9750(10)Å

α=104.779(5)° β=92.572(2)° γ=105.331(2)°

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionohydrazide

C₁₇H₂₈N₂O₂

Xu, Wei-Ming Hu, Xiu-Rong Gu, Jian-Ming

Acta Crystallographica Section E (2005) 61, 12 o4190-o4191

a=6.1848(16)Å b=14.685(5)Å c=19.097(5)Å

α=90.0000° β=95.439(10)° γ=90.0000°

C₁₇H₁₉N₅

Tang, Gu-Ping Gu, Jian-Ming

Acta Crystallographica Section E (2005) 61, 8 o2330-o2331

a=17.9107(8)Å b=11.2522(3)Å c=18.9011(7)Å

α=90° β=121.1810(10)° γ=90°

C₂₄H₃₈La₂O₁₆

Lu, W.-M.Wu, J.-B.Dong, N.Chun, W.-G.Gu, J.-M.Liang, K.-L.

Acta Crystallographica Section C (1995) 51, 8 1568-1570

a=10.060(2)Å b=13.953(5)Å c=23.804(4)Å

α=90.° β=95.27(1)° γ=90.°

N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfanyl)-2-hydroxy- 2-methylpropionamide

C₁₈H₁₄F₄N₂O₂S

Hu, Xiu-Rong Wang, Li-Li Gu, Jian-Ming

Acta Crystallographica Section E (2006) 62, 10 o4545-o4546

a=10.136(5)Å b=10.343(6)Å c=10.524(4)Å

α=106.82(2)° β=116.97(2)° γ=95.19(2)°

Catena-Poly[[tris(1H-benzimidazole-κN^3^)cobalt(II)]-μ-maleato-κ^3^O,O:O'']

C₂₅H₂₀CoN₆O₄

Xue, Yu-Hong Xu, Duan-Jun Gu, Jian-Ming

Acta Crystallographica Section C (2003) 59, 10 m387-m389

a=9.2667(17)Å b=12.1242(15)Å c=21.099(19)Å

α=90° β=90° γ=90°

Memantinium chloride 0.1-hydrate

C₁₂H₂₂N_,Cl_,0.1(H₂O)

Lou, Wei-Jian Hu, Xiu-Rong Gu, Jian-Ming

Acta Crystallographica Section E (2009) 65, 9 o2191

a=28.3787(11)Å b=28.3787(11)Å c=8.5236(4)Å

α=90.00° β=90.00° γ=120.00°

catena-Poly[[bis(dimethylammonium) [cadmate(II)-bis(μ-1,1:4',1''-terphenyl-3,3''-dicarboxylato)]] dimethylformamide disolvate]

2(C₂H₈N)_,C₄₀H₂₄CdO_82,2(C₃H₇NO)

Park, Sang-Wook Gu, Ja-Min Kim, Youngmee Huh, Seong

Acta Crystallographica Section E (2011) 67, 1 m71

a=28.525(4)Å b=9.3267(13)Å c=20.580(3)Å

α=90.00° β=114.752(2)° γ=90.00°

Triamcinolone acetonide acetate

C₂₆H₃₃FO₇

Lu, Xiao Tang, Gu-Ping Gu, Jian-Ming Hu, Xiu-Rong

Acta Crystallographica Section E (2011) 67, 2 o360

a=7.5460(7)Å b=14.8102(4)Å c=11.5773(3)Å

α=90.00° β=109.9050(10)° γ=90.00°

Febuxostat methanol monosolvate

C₁₆H₁₆N₂O₃S_,CH₄O

Jiang, Qi-Ying Qian, Jing-Jing Gu, Jian-Ming Tang, Gu-Ping Hu, Xiu-Rong

Acta Crystallographica Section E (2011) 67, 5 o1232

a=4.7089(3)Å b=17.9073(13)Å c=10.7965(8)Å

α=90.00° β=98.047(2)° γ=90.00°

Quetiapine N-oxide--fumaric acid (2/1)

2(C₂₁H₂₅N₃O₃S)_,C₄H₄O₄

Shen, Jin Qian, Jing-Jing Wu, Su-Xiang Gu, Jian-Ming Hu, Xiu-Rong

Acta Crystallographica Section E (2012) 68, 6 o1753-o1754

a=13.1299(9)Å b=12.5047(8)Å c=13.9950(9)Å

α=90.00° β=101.59(2)° γ=90.00°

N-[1-(3-Chlorophenyl)-1-oxopropan-2-yl]-tert-butanaminium bromide propanol hemisolvate

C₁₃H₁₉ClNO_,Br_,0.5(C₃H₈O)

Liu, Min Hu, Xiu-Rong Gu, Jian-Ming Tang, Gu-Ping

Acta Crystallographica Section E (2011) 67, 10 o2772

a=7.8614(4)Å b=9.4100(6)Å c=11.8477(7)Å

α=85.783(2)° β=78.159(2)° γ=89.450(2)°

7-[(1S,6S)-8-aza-2-azoniabicyclo[4.3.0]non-8-yl]-1-cyclopropyl-6- fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid chloride monohydrate

C₂₁H₂₅FN₃O_4,Cl_,H₂O

Qian, Jing-Jing Gu, Jian-Ming Shen, Jin Hu, Xiu-Rong Wu, Su-Xiang

Acta Crystallographica Section E (2011) 67, 10 o2773-o2774

a=6.7280(3)Å b=10.6406(5)Å c=15.3127(7)Å

α=91.7293(14)° β=91.1313(13)° γ=100.8823(13)°

9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)- 7-oxo-7H-pyrido[1,2,3-ij][1,2,4]benzoxadiazine-6-carboxylic acid

C₁₇H₁₉FN₄O₄

Shen, Jin Qian, Jing-Jing Gu, Jian-Ming Hu, Xiu-Rong

Acta Crystallographica Section E (2012) 68, 4 o998-o999

a=8.0145(5)Å b=8.9218(6)Å c=13.0874(8)Å

α=91.65(3)° β=99.65(3)° γ=115.091(10)°

C₇₂H₃₆In₂O₁₆

Cho, Eun-Young Gu, Ja-Min Choi, In-Hwan Kim, Wan-Seok Hwang, Yong-Kyung Huh, Seong Kim, Sung-Jin Kim, Youngmee

Crystal Growth & Design (2014) 14, 10 5026

a=44.2269(19)Å b=44.2269(19)Å c=42.519(2)Å

α=90.00° β=90.00° γ=120.00°

C_72.67H₄₀In₂O_21.83

Cho, Eun-Young Gu, Ja-Min Choi, In-Hwan Kim, Wan-Seok Hwang, Yong-Kyung Huh, Seong Kim, Sung-Jin Kim, Youngmee

Crystal Growth & Design (2014) 14, 10 5026

a=44.1252(8)Å b=44.1252(8)Å c=42.2961(9)Å

α=90.00° β=90.00° γ=120.00°

C₁₈₅H₇₅In₄NO₃₄

Cho, Eun-Young Gu, Ja-Min Choi, In-Hwan Kim, Wan-Seok Hwang, Yong-Kyung Huh, Seong Kim, Sung-Jin Kim, Youngmee

Crystal Growth & Design (2014) 14, 10 5026

a=45.597(6)Å b=45.597(6)Å c=40.718(8)Å

α=90.00° β=90.00° γ=120.00°

C₁₇H₁₉ClN₂

Hu, Xiu-Rong Gu, Jian-Ming Lu, Guang-Lie

Zeitschrift für Kristallographie - New Crystal Structures (2003) 218, 4 497-498

a=18.0920(1)Å b=5.8896(1)Å c=14.6011(2)Å

α=90° β=90° γ=90°

Structures by: Gu J. M.

Total: 32

C₆₀H₅₀In₂N₂O₁₇

C₅₆H₃₂In₂O₁₆

C₃₂H₁₆InNO₈

C₂₆H₂₄N₂O₄Zn

C₂₃H₂₉ClFN₃O_4,H₂O

Regorafenib crystalline form I

Regorafenib monohydrate

Febuxostat

4-(2-Carbamoyl-1-benzofuran-5-yl)-1-[4-(5-cyano-1<i>H</i>-indol-3-yl)butyl]piperazin-1-ium chloride methanol monosolvate

Canagliflozin

Vortioxetine

1-{2-[(2,4-Dimethylphenyl)sulfanyl]phenyl}piperazine methanol monosolvate

N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfanyl)-2-hydroxy- 2-methylpropionamide chloroform solvate

1-Phenyl-2-(toluene-4-sulfonyl)ethanone

C₁₉H₁₈BrN₃O₃

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionohydrazide

C₁₇H₁₉N₅

C₂₄H₃₈La₂O₁₆

N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfanyl)-2-hydroxy- 2-methylpropionamide

Catena-Poly[[tris(1H-benzimidazole-κN^3^)cobalt(II)]-μ-maleato-κ^3^O,O:O'']

Memantinium chloride 0.1-hydrate

<i>catena</i>-Poly[[bis(dimethylammonium) [cadmate(II)-bis(μ-1,1:4',1''-terphenyl-3,3''-dicarboxylato)]] dimethylformamide disolvate]

Triamcinolone acetonide acetate

Febuxostat methanol monosolvate

Quetiapine <i>N</i>-oxide--fumaric acid (2/1)

<i>N</i>-[1-(3-Chlorophenyl)-1-oxopropan-2-yl]-<i>tert</i>-butanaminium bromide propanol hemisolvate

7-[(1<i>S</i>,6<i>S</i>)-8-aza-2-azoniabicyclo[4.3.0]non-8-yl]-1-cyclopropyl-6- fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid chloride monohydrate

9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)- 7-oxo-7<i>H</i>-pyrido[1,2,3-<i>ij</i>][1,2,4]benzoxadiazine-6-carboxylic acid

C₇₂H₃₆In₂O₁₆

C_72.67H₄₀In₂O_21.83

C₁₈₅H₇₅In₄NO₃₄

C₁₇H₁₉ClN₂